- Home
- HRMY vs DBD Comparison
HRMY vs DBD Comparison
Compare HRMY & DBD Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HRMY
- DBD
- Stock Information
- Founded
- HRMY 2017
- DBD 1859
- Country
- HRMY United States
- DBD United States
- Employees
- HRMY N/A
- DBD N/A
- Industry
- HRMY Biotechnology: Pharmaceutical Preparations
- DBD EDP Services
- Sector
- HRMY Health Care
- DBD Technology
- Exchange
- HRMY Nasdaq
- DBD Nasdaq
- Market Cap
- HRMY 2.0B
- DBD 1.6B
- IPO Year
- HRMY 2020
- DBD N/A
- Fundamental
- Price
- HRMY $39.05
- DBD $44.51
- Analyst Decision
- HRMY Strong Buy
- DBD Strong Buy
- Analyst Count
- HRMY 8
- DBD 2
- Target Price
- HRMY $55.00
- DBD $57.50
- AVG Volume (30 Days)
- HRMY 593.9K
- DBD 103.8K
- Earning Date
- HRMY 02-20-2025
- DBD 02-12-2025
- Dividend Yield
- HRMY N/A
- DBD N/A
- EPS Growth
- HRMY N/A
- DBD N/A
- EPS
- HRMY 2.11
- DBD 0.00
- Revenue
- HRMY $681,879,000.00
- DBD $3,799,000,000.00
- Revenue This Year
- HRMY $24.79
- DBD $0.73
- Revenue Next Year
- HRMY $19.00
- DBD $1.58
- P/E Ratio
- HRMY $18.55
- DBD $8,356.71
- Revenue Growth
- HRMY 25.83
- DBD 2.88
- 52 Week Low
- HRMY $28.14
- DBD $29.63
- 52 Week High
- HRMY $41.61
- DBD $51.81
- Technical
- Relative Strength Index (RSI)
- HRMY 71.30
- DBD 55.38
- Support Level
- HRMY $35.72
- DBD $39.90
- Resistance Level
- HRMY $37.16
- DBD $43.46
- Average True Range (ATR)
- HRMY 1.29
- DBD 1.01
- MACD
- HRMY 0.48
- DBD 0.19
- Stochastic Oscillator
- HRMY 92.25
- DBD 94.86
About HRMY Harmony Biosciences Holdings Inc.
Harmony Biosciences Holdings Inc is a commercial-stage pharmaceutical company focused on developing and commercializing therapies for patients living with rare neurological diseases who have unmet medical needs. The company's product WAKIX (pitolisant), is a molecule with a novel mechanism of action specifically designed to increase histamine signaling in the brain by binding to H3 receptors and used for the treatment of cataplexy in adult patients with narcolepsy.
About DBD Diebold Nixdorf Incorporated Common stock
Diebold Nixdorf Inc is engaged in providing software and hardware services for financial and retail industries. The customer segments of the company are banking which offers integrated solutions for financial institutions and retail which offers solutions, software, and services which improve the checkout process for retailers.